Tag: Pharmaceuticals
Mirum Pharmaceuticals Investor Call: Volixibat VANTAGE & VISTAS Studies Analysis Results, June 17, 2024
Mirum Pharmaceuticals, Inc. recently held an investor call to discuss the interim analysis results from two important studies involving the drug Volixibat. The Volixibat VANTAGE Phase 2b study focused on primary biliary cholangitis (PBC),...
Moderna Investors Just Got Some Bullish News
Moderna's Latest Breakthrough in RSV Vaccine Approval Signals Potential Market GrowthModerna, a well-known biotech company that gained prominence during the development of a successful coronavirus vaccine, has recently received positive news that could mark...




